These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 3738429)
21. Future Directions in the Evaluation and Treatment of Precursor Plasma Cell Disorders. Manier S; Salem KZ; Liu D; Ghobrial IM Am Soc Clin Oncol Educ Book; 2016; 35():e400-6. PubMed ID: 27249747 [TBL] [Abstract][Full Text] [Related]
22. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire. Pérez-Andres M; Almeida J; Martin-Ayuso M; Moro MJ; Martin-Nuñez G; Galende J; Hernandez J; Mateo G; San Miguel JF; Orfao A; ; Cancer; 2006 Mar; 106(6):1296-305. PubMed ID: 16475149 [TBL] [Abstract][Full Text] [Related]
23. Multiple myeloma arising from monoclonal gammopathy of undetermined significance in a patient with Gaucher's disease. Brady K; Corash L; Bhargava V Arch Pathol Lab Med; 1997 Oct; 121(10):1108-11. PubMed ID: 9341594 [TBL] [Abstract][Full Text] [Related]
24. Plasma cell dyscrasias: classification, clinical and laboratory characteristics, and differential diagnosis. Boccadoro M; Pileri A Baillieres Clin Haematol; 1995 Dec; 8(4):705-19. PubMed ID: 8845568 [TBL] [Abstract][Full Text] [Related]
26. Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells. Barker HF; Hamilton MS; Ball J; Drew M; Franklin IM Br J Haematol; 1992 Jul; 81(3):331-5. PubMed ID: 1382543 [TBL] [Abstract][Full Text] [Related]
27. CD28, a marker associated with tumoral expansion in multiple myeloma. Robillard N; Jego G; Pellat-Deceunynck C; Pineau D; Puthier D; Mellerin MP; Barillé S; Rapp MJ; Harousseau JL; Amiot M; Bataille R Clin Cancer Res; 1998 Jun; 4(6):1521-6. PubMed ID: 9626472 [TBL] [Abstract][Full Text] [Related]
28. Ultrastructural characteristics of the plasma cells of a patient with nonsecretory myeloma and plasma cell leukemia. Bassan H; Gutmann H; Djaldetti M Acta Haematol; 1981; 66(2):129-33. PubMed ID: 6794313 [TBL] [Abstract][Full Text] [Related]
29. [IgG-lambda-type multiple myeloma with plasma-cell pericardial effusion and terminal plasma-cell leukemia]. Klug S; Höltermann F; Fritsch H Dtsch Med Wochenschr; 1992 Jun; 117(23):900-4. PubMed ID: 1597118 [TBL] [Abstract][Full Text] [Related]
30. Plasma cell morphology in multiple myeloma and related disorders. Ribourtout B; Zandecki M Morphologie; 2015 Jun; 99(325):38-62. PubMed ID: 25899140 [TBL] [Abstract][Full Text] [Related]
31. Multiple myeloma and secondary plasma cell leukemia. Dos Santos VM; Melim SP; de Faria PS; Passini VV; Duarte ML; Casasanta RA Rom J Morphol Embryol; 2016; 57(2 Suppl):837-839. PubMed ID: 27833979 [TBL] [Abstract][Full Text] [Related]
32. [Phagocytic plasma cells in a patient with Bence Jones (lambda type) myeloma, with a special reference to phagocytic activity of plasma cells (author's transl)]. Fujii H; Shimizu T; Seki S; Isemura T; Yamamoto K; Kanoh T; Oono Y Rinsho Ketsueki; 1981 Jul; 22(7):1196-203. PubMed ID: 7328773 [No Abstract] [Full Text] [Related]
33. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia. Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602 [TBL] [Abstract][Full Text] [Related]
34. Peripheral blood dendritic cell subsets from patients with monoclonal gammopathies show an abnormal distribution and are functionally impaired. Martín-Ayuso M; Almeida J; Pérez-Andrés M; Cuello R; Galende J; González-Fraile MI; Martín-Nuñez G; Ortega F; Rodríguez MJ; San Miguel JF; Orfao A Oncologist; 2008 Jan; 13(1):82-92. PubMed ID: 18245015 [TBL] [Abstract][Full Text] [Related]
35. Multiple myeloma presenting as primary non-secretory plasma cell leukemia. Khunger JM; Sharma M; Talib VH Indian J Pathol Microbiol; 2003 Jan; 46(1):104-5. PubMed ID: 15027746 [TBL] [Abstract][Full Text] [Related]
36. Interaction between clonal plasma cells and the immune system in plasma cell dyscrasias. Perez-Andres M; Almeida J; Martin-Ayuso M; Moro MJ; Garcia-Marcos MA; Moreno I; Dominguez M; Galende J; Heras N; Gonzalez MI; San Miguel JF; Orfao A; J Biol Regul Homeost Agents; 2004; 18(2):161-5. PubMed ID: 15471221 [TBL] [Abstract][Full Text] [Related]
37. In vitro endocytosis of benign and malignant human bone marrow plasma cells. Ohtake K; Yano T; Kameda K; Ogawa T Am J Hematol; 1990 Oct; 35(2):100-3. PubMed ID: 2205094 [TBL] [Abstract][Full Text] [Related]
38. Pathologic studies useful for the diagnosis and monitoring of plasma cell dyscrasias. Veillon DM; Cotelingam JD Contrib Nephrol; 2007; 153():25-43. PubMed ID: 17075222 [TBL] [Abstract][Full Text] [Related]
39. Human herpesvirus 8 genome is not found in whole bone marrow core biopsy specimens of patients with plasma cell dyscrasias. Drabick JJ; Davis BJ; Lichy JH; Flynn J; Byrd JC Ann Hematol; 2002 Jun; 81(6):304-7. PubMed ID: 12107558 [TBL] [Abstract][Full Text] [Related]